Volume 42, Issue 6, Pages (June 2005)

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.
Global gene repression in hepatocellular carcinoma and fetal liver, and suppression of dudulin-2 mRNA as a possible marker for the cirrhosis-to-tumor transition.
Volume 61, Issue 1, Pages (July 2014)
Volume 46, Issue 3, Pages (March 2007)
Novel Serum Markers of Fibrosis Progression for the Follow-Up of Hepatitis C Virus- Infected Patients  Frédérique Caillot, Martine Hiron, Odile Goria,
Inflammasomes in liver diseases
Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies  Gennaro D'Amico, Guadalupe Garcia-Tsao, Luigi.
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review  Christian Thoma, Christopher P. Day, Michael.
Identification of synovial fluid microRNA signature in knee osteoarthritis: differentiating early- and late-stage knee osteoarthritis  Y.-H. Li, G. Tavallaee,
Molecular phenotyping of HCS-2/8 cells as an in vitro model of human chondrocytes  J. Saas, Ph.D., K. Lindauer, Ph.D., B. Bau, M.Sc., M. Takigawa, D.D.S.,
M. Fu, G. Huang, Z. Zhang, J. Liu, Z. Zhang, Z. Huang, B. Yu, F. Meng 
Volume 61, Issue 6, Pages (December 2014)
Cédric Coulouarn, Bruno Clément  Journal of Hepatology 
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
Kenneth G. Geles, Wenyan Zhong, Siobhan K
Immigration and viral hepatitis
Florie Borel, Pavlina Konstantinova, Peter L.M. Jansen 
Individualized prediction of hepatocellular carcinoma occurrence in a large cohort of patients with cirrhosis  Astrid Marot, Jean Henrion, Jean-François.
Gene expression profiling of human peri-implantation endometria between natural and stimulated cycles  Yunao Liu, M.Sc., Kai-Fai Lee, Ph.D., Ernest H.Y.
Volume 44, Issue 5, Pages (November 2003)
Total-Genome Analysis of BRCA1/2-Related Invasive Carcinomas of the Breast Identifies Tumor Stroma as Potential Landscaper for Neoplastic Initiation 
Living donor liver transplantation: is the hype over?
Array-CGH Reveals Recurrent Genomic Changes in Merkel Cell Carcinoma Including Amplification of L-Myc  Kelly G. Paulson, Bianca D. Lemos, Bin Feng, Natalia.
Volume 67, Issue 6, Pages (June 2005)
A microRNA profile comparison between thoracic aortic dissection and normal thoracic aorta indicates the potential role of microRNAs in contributing to.
Identification of synovial fluid microRNA signature in knee osteoarthritis: differentiating early- and late-stage knee osteoarthritis  Y.-H. Li, G. Tavallaee,
The place of downstaging for hepatocellular carcinoma
Volume 58, Issue 3, Pages (March 2013)
Volume 20, Issue 12, Pages (September 2017)
Reply to: “Low free T3 levels are related to early mortality in patients with decompensated cirrhosis and acute-on chronic liver failure”  Rakhi Maiwall,
Cheng-Yuan Peng, Rong-Nan Chien, Yun-Fan Liaw  Journal of Hepatology 
Volume 68, Issue 1, Pages (January 2018)
Volume 135, Issue 1, Pages (July 2008)
Riccardo Lencioni, Fabio Piscaglia, Luigi Bolondi 
Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study  Gyuri Kim, Suk-Yong Jang, Chung.
Genomic risk of hepatitis C-related hepatocellular carcinoma
Expression profiling of non–small cell lung carcinoma identifies metastatic genotypes based on lymph node tumor burden  Chuong D. Hoang, MD, Jonathan.
Hepatic hepcidin expression is decreased in cirrhosis and HCC
Autophagy in the liver Journal of Hepatology
Volume 44, Issue 2, Pages (February 2006)
Volume 12, Issue 6, Pages (December 2003)
Volume 54, Issue 5, Pages (May 2011)
miR-210 Is a Prognostic Marker in Clear Cell Renal Cell Carcinoma
Volume 71, Issue 9, Pages (May 2007)
Molecular prognostication of liver cancer: End of the beginning
Cédric Coulouarn, Bruno Clément  Journal of Hepatology 
Non-invasive diagnosis and biomarkers in alcohol-related liver disease
Hepatic gene induction in murine bone marrow after hepatectomy
Chetana Lim, Chady Salloum, Daniel Azoulay
Gene Expression Profiles of Cutaneous B Cell Lymphoma
Immigration and viral hepatitis
Evolution of liver transplantation for hepatocellular carcinoma
Kornelius Schulze, Jean-Charles Nault, Augusto Villanueva 
Global burden of alcoholic liver diseases
R.H. Brophy, B. Zhang, L. Cai, R.W. Wright, L.J. Sandell, M.F. Rai 
Changes in the 24-h plasma cortisol rhythm in patients with cirrhosis
Volume 67, Issue 5, Pages (November 2017)
Role of desmoplasia in cholangiocarcinoma and hepatocellular carcinoma
Volume 39, Issue 6, Pages (December 2003)
Hepatic gene induction in murine bone marrow after hepatectomy
Volume 66, Issue 3, Pages (March 2017)
Volume 26, Issue 7, Pages e4 (February 2019)
Volume 65, Issue 4, Pages (October 2016)
New trials and results in systemic treatment of HCC
Pathogenesis of cholestatic hepatitis C
Genetic alterations in advanced HBV-related HCC with portal vein tumor thrombosis: Insights from next generation DNA sequencing  Roongruedee Chaiteerakij,
Volume 41, Issue 2, Pages (August 2004)
Genetics of hepatocellular carcinoma: The next generation
Inhibition of CD20 mRNA expression by ibrutinib correlates with reduced NF-κB activity. Inhibition of CD20 mRNA expression by ibrutinib correlates with.
Presentation transcript:

Volume 42, Issue 6, Pages 860-869 (June 2005) Global gene repression in hepatocellular carcinoma and fetal liver, and suppression of dudulin-2 mRNA as a possible marker for the cirrhosis-to-tumor transition  Cédric Coulouarn, Céline Derambure, Grégory Lefebvre, Romain Daveau, Martine Hiron, Michel Scotte, Arnaud François, Maryvonne Daveau, Jean-Philippe Salier  Journal of Hepatology  Volume 42, Issue 6, Pages 860-869 (June 2005) DOI: 10.1016/j.jhep.2005.01.027 Copyright © 2005 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Similarities and differences in mRNA levels regulated in early, late FL and/or HCCs vs controls. The diagrams depict the numbers of mRNAs whose levels were found to be up- or down-regulated in a given condition vs controls (A) or in a similar or opposite direction between conditions (B). A given mRNA was included whenever it was found to be regulated in at least the early or late FL or at least three out of nine HCC samples as compared to its average value in four control adult livers, as determined by microarray. In A, the total number of mRNAs is only 1436, for redundancy between subsets. Journal of Hepatology 2005 42, 860-869DOI: (10.1016/j.jhep.2005.01.027) Copyright © 2005 European Association for the Study of the Liver Terms and Conditions

Fig. 2 Clustering of liver sources by PCA. The 1436 mRNA levels found to be significantly up- or down-regulated in at least early or late FL (open square) or three HCCs (closed triangle 1–9) as compared to their mean level in control livers (open dot 1–4), i.e. the 1436 mRNAs in Fig. 1A, were used for PCA. The axes depict the first three variance components of the mRNAs included in the analysis, which together represent 84.9% of the total variance. Journal of Hepatology 2005 42, 860-869DOI: (10.1016/j.jhep.2005.01.027) Copyright © 2005 European Association for the Study of the Liver Terms and Conditions

Fig. 3 Clustering of samples or mRNAs by bi-dimensional hierarchical clustering. The 425 mRNAs found to be significantly regulated in at least early FL or late FL, as well as in at least three HCC samples as compared to their mean level in controls, i.e. the 425 mRNAs in Fig. 1B, were used for bi-dimensional hierarchical clustering (average linkage option). The samples are clustered horizontally and the mRNAs are clustered vertically (the gene symbols are omitted). In every sample a change (fold) in a given mRNA level relative to its mean level in the four control samples is shown as a colored bar of variable intensity (scale at the bottom). Subsets I or II contain mRNAs that are, respectively, down- or up-regulated in late FL and HCCs. Subset III contains mRNAs that are down-regulated in early FL, late FL and HCCs. Journal of Hepatology 2005 42, 860-869DOI: (10.1016/j.jhep.2005.01.027) Copyright © 2005 European Association for the Study of the Liver Terms and Conditions

Fig. 4 q-RT-PCR of dudulin-2 mRNA. The patients are all those listed in Table 1. All values (bar: mean) are expressed as a percent of the highest abundance (100%) found in one of the samples (C, control liver; CIR, cirrhosis; T, tumor). ES1-4 refers to the tumor differentiation grade 1–4 [46]. The Student's t test for two samples was used for comparison of any group vs the control patients (⋆, P<0.05; $, P<0.01). The Wilcoxon's matched-pairs signed ranks test was used for comparisons of paired samples (significance noted above an horizontal bracket). Journal of Hepatology 2005 42, 860-869DOI: (10.1016/j.jhep.2005.01.027) Copyright © 2005 European Association for the Study of the Liver Terms and Conditions